Literature DB >> 10936136

Health status and sociodemographic characteristics of adults receiving a cystic fibrosis diagnosis after age 18 years.

E Widerman1, L Millner, W Sexauer, S Fiel.   

Abstract

OBJECTIVES: An increasing percentage of cystic fibrosis (CF) diagnoses are occurring in adulthood. The purpose of this study was to explore how age at diagnosis may be associated with selected disease and sociodemographic characteristics.
DESIGN: The 1996 Cystic Fibrosis Foundation (CFF) Patient Registry data were analyzed to test for associations between age at diagnosis and selected variables. All cases involved individuals > or = 18 years who were represented in the CFF Patient Registry for 1996. Patients were assigned to one of two groups: those diagnosed with CF after age 18 years (n = 786) and those diagnosed before 18 years (n = 6,641).
RESULTS: In 1996, the incidence of late diagnosis was 7.8%, and the prevalence was 10.9%. The mean age of late diagnosis was 27 years. Respiratory symptoms most frequently led to late diagnosis. Patients receiving a late CF diagnosis were less likely to have alleles for Delta F508. There was no correlation between age at diagnosis and percent predicted FEV(1), although patients in the late-diagnosis group were an average of 10 years older than those in the early-diagnosis group. Late diagnosis was associated with fewer complications, fewer hospitalizations, less oxygen use, fewer courses of home IV treatment, and less enzyme use. Women were most often diagnosed late. Men displayed more diversity in conditions leading to diagnosis. Psychosocially, those patients receiving late diagnoses were more likely to be college graduates, married, and employed full time. For those adults who died in 1996, there was a positive association between their age at diagnosis and age at death.
CONCLUSION: Those patients diagnosed with CF as adults differ, both medically and psychosocially, from those diagnosed at a younger age; these differences have implications for diagnosis, treatment, and education.

Entities:  

Mesh:

Year:  2000        PMID: 10936136     DOI: 10.1378/chest.118.2.427

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.

Authors:  Jerry A Nick; Cathy S Chacon; Sara J Brayshaw; Marion C Jones; Christine M Barboa; Connie G St Clair; Robert L Young; David P Nichols; Jennifer S Janssen; Gwen A Huitt; Michael D Iseman; Charles L Daley; Jennifer L Taylor-Cousar; Frank J Accurso; Milene T Saavedra; Marci K Sontag
Journal:  Am J Respir Crit Care Med       Date:  2010-05-06       Impact factor: 21.405

2.  Cystic fibrosis in adults.

Authors:  Ilma Aparecida Paschoal; Wander de Oliveira Villalba; Carmen Sílvia Bertuzzo; Elza Maria F P Cerqueira; Mônica Corso Pereira
Journal:  Lung       Date:  2007-02-09       Impact factor: 2.584

3.  Using spirituality after an adult CF diagnosis: cognitive reframing and adherence motivation.

Authors:  Daniel H Grossoehme; Judith R Ragsdale; Sian Cotton; Melenie A Meyers; John P Clancy; Michael Seid; Patricia M Joseph
Journal:  J Health Care Chaplain       Date:  2012

4.  Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.

Authors:  Claire L Keating; Xinhua Liu; Emily A Dimango
Journal:  Chest       Date:  2009-12-04       Impact factor: 9.410

Review 5.  Atypical cystic fibrosis: identification in the primary care setting.

Authors:  Carrie A Schram
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

6.  A salty cause of cough in a 24-year-old man.

Authors:  Neda Naderi; Soheil Peiman; Azam Alamdari; Taraneh Dormohammadi Toosi; Foad Taghdiri
Journal:  Oxf Med Case Reports       Date:  2014-07-01

7.  How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old.

Authors:  C Prados; M Lerín; J J Cabanillas; L Gómez-Carrera; R Álvarez-Sala
Journal:  Respir Med Case Rep       Date:  2017-03-24

8.  Genetic influences on cystic fibrosis lung disease severity.

Authors:  Colleen A Weiler; Mitchell L Drumm
Journal:  Front Pharmacol       Date:  2013-04-23       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.